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correlation observed between plasma IL-6 and IL-8 con- 
centrations (p = 0.91; p - 0.02, Spearman rank order 
test), the level of IL-10 production was unrelated to the 
levels of IL-8 and IL-6. 
Our results how that CPB causes the rapid and transient 
release of IL-10. The differences in kinetics and levels of 
production between IL-10 and IL-6 and IL-8 suggest differ- 
ent immunoregulatory mechanisms involved in their secre- 
tions. The in vivo kinetics of IL-10 during CPB are similar to 
those observed in experimental routine endotoxemia after 
lipopolysaccharide challenge. 4 These kinetics contrast with 
in vitro data showing that IL-10 is produced rather late after 
lipopolysaccharide stimulation of human monocytes 5 and 
suggest that other Cells could be involved in the release of 
IL-10 in vivo. The cellular source(s) of IL-10 and the nature 
of stimuli leading to IL-10 release remain to be determined. 
We concluded that CPB induced an early IL-10 secretion. 
Further studies are required to determine whether this IL-10 
release plays a beneficial role, by reducing the ischemia- 
reperfusion i flammatory esponse, or a detrimental role, by 
decreasing the cellular immune response. 
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Intraoperative use of  end-t idal  carbon dioxide 
tension to assess cardiac output 
To the Editor: 
We read with interest he letter by Feng and Singh 1 on 
the intraoperative monitoring of end-tidal carbon dioxide 
tension (PETCOa) to assess cardiac output during weaning 
from cardiopulmonary b pass (CPB). The authors invited 
comment from those who might have made similar obser- 
vations. 
We have observed for some time that PETCO 2 is a good 
indicator of cardiac performance during weaning from 
CPB. It is our practice to monitor and record PETCO2 
continuously in the prebypass period, adjusting minute 
volume and tidal volume to achieve a PETCO2 of approx- 
imately 4 kPa (30 mm Hg) before bypass. On reinstitution 
Of ventilation and reperfusion of the lungs, we set the 
ventilator to deliver the same minute volume and tidal 
volume as before bypass, in the absence of major meta- 
bolic changes or a major change in dead space, either of 
which we believe occurs rarely, PETCO2 will directly 
reflect carbon dioxide, as explained by Feng and Singh. In 
our experience patients tend to fall into one of three 
groups. The first group comprises those in whom the 
PETCO 2 level is similar to that recorded before CPB. 
These patients generally are able to be weaned readily 
from CPB with minimal additional volume requirement 
and without recourse to inotropic agents or assist devices. 
The second group demonstrates an initial PETCO 2 level 
lower than that recorded before CPB, but this gradually 
returns to the prebypass level. These patients appear to 
commonly require preload augmentation before being 
successfully weaned. Last is a group that has persistent 
low PETCO/levels. These patients will commonly require 
more volume and often require inotropic support or 
occasionally assist devices to be weaned successfully. We 
have a very low threshold for instituting inotropic support 
in patients wh6 have low PETCO2 during weaning from 
CPB despite adequate preload and satisfactory heart rate 
andrhythm. 
At present, because we do not routinely monitor intra- 
operative cardiac output, we have not objectively con- 
firmed the clinical impression that we have described. We 
intend to study the matter in detail later this year. 
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